Maven Securities’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Maven Securities’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60,000	Closed	-$1.45M	–	1105
2023 Q1	$1.45M	Buy	+60,000	New	+$753K	0.03%	369

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Maven Securities's PRVB Position: Q4 2019 in Review

Maven Securities sold out of Provention Bio, Inc. Common Stock (PRVB) in Q4 2019, closing a stake of 228,700 shares — an estimated $1.7M sold.

Maven Securities first reported a position in PRVB in Q3 2019 and held it in 1 quarter. The position peaked at $1.7M in Q3 2019. 60 funds tracked by Wall St. Rank hold PRVB as of Q4 2019.

Maven Securities reported no remaining Provention Bio, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Maven Securities sold 228,700 Provention Bio, Inc. Common Stock shares in Q4 2019, an estimated $1.7M.
Maven Securities first reported a position in Provention Bio, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
Maven Securities's Provention Bio, Inc. Common Stock position peaked at $1.7M in Q3 2019.
60 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q4 2019.

Based on Maven Securities's 13F filing for Q4 2019, filed 14 Feb 2020.